Table:
begin	end	state
1	57	cytoplasmic
58	79	transmembrane
80	87	non-cytoplasmic
88	108	transmembrane
109	122	cytoplasmic
123	142	transmembrane
143	147	non-cytoplasmic
148	170	transmembrane
171	181	cytoplasmic
182	205	transmembrane
206	216	non-cytoplasmic
217	237	transmembrane
238	284	cytoplasmic
285	306	transmembrane
307	322	non-cytoplasmic
323	343	transmembrane
344	350	cytoplasmic
351	367	transmembrane
368	372	non-cytoplasmic
373	394	transmembrane
395	404	cytoplasmic
405	428	transmembrane
429	439	non-cytoplasmic
440	459	transmembrane
460	480	cytoplasmic

Input:
>Pf6N2E2_2115
LSSKKFKLYDVYQHRHLHDAPHKNNEWEKNQVNTSSLKANAGADPVLLSAIAKVKRHILP
LFVIMFIVNYIDRVNIGFVRAHMEHDLGIGAAAYGLGAGLFFVGYALFEVPSNILLQRIG
ARIWLTRIMLTWGLVAAAMAFIQNETHFYILRFLLGVAEAGFFPGVIYYFTRWLPGVERG
KAIAIFLSGSAIASLISGPLSGLLLQINGLGMHGWQWMYFIEGMFSVCLCVFVWFWLDSK
PHDAKWLSREEQDVLVKTIDDEQRAREAASPIKLSIGQLLKDRQIILFCLIYFFIQLTIY
AATFWLPSIIKKMGELSDIQVGMFNSIPWLLSIVGMYAFASLSAKWKFQQAWVATALLIA
AAGMFMSTTGGPIFAFVAICFAALGFKSASSLFWPIPQAYLDARIAAGVIALINSVGNLG
GFVAPTTFGLLEEHTGSIQGGLYGLAATSIIAAIIVFAARNTPKPKSATTPANPPAASHV

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server